Log In
Tuesday 20th February 2018

Drug shrinks brain tumour by 50%

27th September 2011

The drug Votubia (everolimus), which has the ability to decrease the size of brain tumours by 50%, has been launched in the UK.

The drug will be available to NHS doctors, who can apply to use the drug to treat children with non-malignant brain tumours linked with the condition tuberous sclerosis complex. Chris Kingswood, head of research at the Tuberous Sclerosis Association, said: "Everolimus is the first licensed product we can offer patients to attack the cause of their debilitating condition; it works by blocking a protein that acts as an important regulator of tumour cell growth." 

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Drug shrinks brain tumour by 50%
Author: Jess Laurence
Article Id: 19881
Date Added: 27th Sep 2011


Recent Related Articles

Prescription drug addiction to be reviewed

Thyroid drug will remain available on the NHS

Scarlet fever hits 50-year high

NHS overcharged for key drug


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018